Literature DB >> 29053790

The Hippo Signaling Pathway in Pancreatic β-Cells: Functions and Regulations.

Amin Ardestani1, Kathrin Maedler1.   

Abstract

Hippo signaling is an evolutionarily conserved pathway that critically regulates development and homeostasis of various tissues in response to a wide range of extracellular and intracellular signals. As an emerging important player in many diseases, the Hippo pathway is also involved in the pathophysiology of diabetes on the level of the pancreatic islets. Multiple lines of evidence uncover the importance of Hippo signaling in pancreas development as well as in the regulation of β-cell survival, proliferation, and regeneration. Hippo therefore represents a potential target for therapeutic agents designed to improve β-cell function and survival in diabetes. In this review, we summarize recent data on the regulation of the Hippo signaling pathway in the pancreas/in pancreatic islets, its functions on β-cell homeostasis in physiology and pathophysiology, and its contribution toward diabetes progression. The current knowledge related to general mechanisms of action and the possibility of exploiting the Hippo pathway for therapeutic approaches to block β-cell failure in diabetes is highlighted.
Copyright © 2018 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29053790     DOI: 10.1210/er.2017-00167

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  13 in total

Review 1.  Role of YAP/TAZ in Energy Metabolism in the Heart.

Authors:  Toshihide Kashihara; Junichi Sadoshima
Journal:  J Cardiovasc Pharmacol       Date:  2019-12       Impact factor: 3.105

2.  YAP1 is involved in replenishment of granule cell precursors following injury to the neonatal cerebellum.

Authors:  Zhaohui Yang; Alexandra L Joyner
Journal:  Dev Biol       Date:  2019-07-31       Impact factor: 3.582

Review 3.  Transcription factor GLIS3: Critical roles in thyroid hormone biosynthesis, hypothyroidism, pancreatic beta cells and diabetes.

Authors:  David W Scoville; Hong Soon Kang; Anton M Jetten
Journal:  Pharmacol Ther       Date:  2020-07-18       Impact factor: 12.310

4.  TAZ promotes PDX1-mediated insulinogenesis.

Authors:  Mi Gyeong Jeong; Hyo Kyeong Kim; Gibbeum Lee; Hee Yeon Won; Da Hye Yoon; Eun Sook Hwang
Journal:  Cell Mol Life Sci       Date:  2022-03-13       Impact factor: 9.261

Review 5.  MicroRNAs as the promising markers of comorbidities in childhood obesity-A systematic review.

Authors:  Michał Hutny; Jagoda Hofman; Agnieszka Zachurzok; Paweł Matusik
Journal:  Pediatr Obes       Date:  2021-12-16       Impact factor: 3.910

6.  Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in breast cancer.

Authors:  Lihua Wang; Canwei Wang; Zheying Tao; Liqian Zhao; Zheng Zhu; Wencan Wu; Ye He; Hong Chen; Bin Zheng; Xiangjie Huang; Yun Yu; Linjun Yang; Guang Liang; Ri Cui; Tongke Chen
Journal:  J Exp Clin Cancer Res       Date:  2019-11-08

Review 7.  Hippo Signaling Pathway in Pancreas Development.

Authors:  Yifan Wu; Pauline Aegerter; Michael Nipper; Logan Ramjit; Jun Liu; Pei Wang
Journal:  Front Cell Dev Biol       Date:  2021-05-17

8.  Loss of Deubiquitinase USP1 Blocks Pancreatic β-Cell Apoptosis by Inhibiting DNA Damage Response.

Authors:  Kanaka Durga Devi Gorrepati; Blaz Lupse; Karthika Annamalai; Ting Yuan; Kathrin Maedler; Amin Ardestani
Journal:  iScience       Date:  2018-03-23

Review 9.  β-Cell Maturation and Identity in Health and Disease.

Authors:  Ciro Salinno; Perla Cota; Aimée Bastidas-Ponce; Marta Tarquis-Medina; Heiko Lickert; Mostafa Bakhti
Journal:  Int J Mol Sci       Date:  2019-10-30       Impact factor: 5.923

Review 10.  Apoptosis in Type 2 Diabetes: Can It Be Prevented? Hippo Pathway Prospects.

Authors:  Agnieszka Kilanowska; Agnieszka Ziółkowska
Journal:  Int J Mol Sci       Date:  2022-01-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.